de los Pinos Elisabet's Insider Trades & SAST Disclosures
de los Pinos Elisabet's most recent trade in Aura Biosciences Inc was a trade of 20,221 Common Stock done at an average price of $7.8 . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern de los Pinos Elisabet.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 7.75 per share. | 18 Feb 2025 | 20,221 | 482,440 | - | 7.8 | 156,796 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 255,680 | 255,680 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 194,320 | 502,661 | - | 0 | Common Stock | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 7.67 per share. | 21 Jan 2025 | 15,955 | 304,692 | - | 7.7 | 122,381 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.74 per share. | 29 Oct 2024 | 9,200 | 320,647 | - | 10.7 | 98,788 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2024 | 24,992 | 336,171 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.04 per share. | 18 Oct 2024 | 24,992 | 329,847 | - | 12.0 | 300,839 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.74 per share. | 18 Oct 2024 | 24,992 | 354,839 | - | 2.7 | 68,478 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.76 per share. | 27 Sep 2024 | 5,474 | 329,847 | - | 5.8 | 31,530 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2024 | 5,474 | 0 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | de los Pinos Elisabet | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 237,065 | 237,065 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | de los Pinos Elisabet | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 162,935 | 324,373 | - | 0 | Common Stock | |
| Aura Biosciences Inc | de los Pinos Elisabet | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 7.64 per share. | 23 Jan 2024 | 15,853 | 161,438 | - | 7.6 | 121,141 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 121,875 | 190,526 | - | 0 | Common Stock | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.46 per share. | 31 Oct 2022 | 5,706 | 68,651 | - | 12.5 | 71,082 | Common Stock |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | 02 Nov 2021 | 4,552 | 131,412 | - | 0 | Common Stock | ||
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | 02 Nov 2021 | 3,042 | 0 | - | - | Series A-1 Preferred Stock | ||
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | 02 Nov 2021 | 1,510 | 0 | - | - | Series A-2 Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges